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Letter to the Editor
MALIGNANT MELANOMA AND ORAL CONTRACEPTIVES
SIR,-The paper from Adam et al. (Br. J.
Cancer, 44,45 (1981)) recordstheobservations
from a case-control study and also from the
Oxford/Family Planning Association pros-
pective study.
I should like to record the relevant obser-
vations from the other continuing major
British prospective study.* Up to December
1979, 40 cases had been reported to us
coded ICD 172; 24 occurred in ever-users of
oral contraceptives, and 16 in the control
subjects who had never used the Pill.
The respective standardized rates and
periods of observation for ever users and
controls were 0-15 per thousand women years
(176,693 women years) and 0-11 (129,593
women years). The relative risk, derived
from the standardized rates, was 1 46
(95% confidence limits 0-73-2 91).
Our data, therefore, support the view of
Adam et al, that there is no convincing
evidence of an association between oral
contraceptive use and the development of
malignant melanoma in women in the UK.
3 July 1981 C. R. KAY
Director, Manchester Research Unit, Oral
Contraception Study, The Royal College of
General Practitioners, 8 Barlow Moor Road,
Manchester
* Begun in 1974 with the publication of Oral Contraceptives and Health, Royal College of Genera
Practitioners. London: Pitman Medical.